INSYS Therapeutics, Inc. to Participate in Oppenheimer Specialty Pharma Summit
October 09 2017 - 12:00PM
INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”)
announced today that Saeed Motahari, president and chief executive
officer, and Andrew Long, chief financial officer, will participate
in the Oppenheimer Specialty Pharma Summit to be held Oct. 11, 2017
at the Sofitel Hotel in New York.
Management will provide an overview of the company’s business in
one-on-one meetings with investors who are registered to attend the
conference. The presentation slides will be available during the
conference and can be accessed by visiting the News & Events
page of the Investors section of the company’s website at
https://www.insysrx.com/.
About INSYSINSYS Therapeutics is a specialty
pharmaceutical company that develops and commercializes innovative
drugs and novel drug delivery systems of therapeutic molecules that
improve patients’ quality of life. Using proprietary spray
technology and capabilities to develop pharmaceutical cannabinoids,
INSYS is developing a pipeline of products intending to address
unmet medical needs and the clinical shortcomings of existing
commercial products. INSYS currently markets SUBSYS® (fentanyl
sublingual spray), CII, and SYNDROS® (dronabinol) oral solution,
CII, a proprietary, orally administered liquid formulation of
dronabinol. INSYS is committed to developing medications for
potentially treating addiction to opioids, opioid overdose,
epilepsy, and other disease areas with a significant unmet
need.
SUBSYS® and SYNDROS® are trademarks of INSYS Development
Company, Inc., a subsidiary of INSYS Therapeutics, Inc.
NOTE: All trademarks and registered trademarks are the property
of their respective
owners.
CONTACT:
Media RelationsJoe McGrathSenior Director, Corporate
CommunicationsINSYS
Therapeutics480-500-3101jmcgrath@insysrx.com
Investor RelationsJackie Marcus or Chris HodgesAlpha IR
Group312-445-2870INSY@alpha-ir.com
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Mar 2024 to Apr 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Apr 2023 to Apr 2024